Clinical Flow Cytometer-CytoPOC Small Highly Integrated
- Point of origin
- China ISO13485 ISO9001
- Testing item
- Hematology, Immunology, Transplantation, Oncology, and Infectious Diseases
- Application scenarios
- clinical laboratory,Clinic,hospital ,Blood routine
As an advanced bioanalytical instrument, CytoPOC flow cytometer meets clinical needs for efficient and accurate diagnosis with its unique single light source four-color configuration, fixed non-dimming path, and dual-platform absolute counting technology. Functions such as one-key operation, intelligent analysis, and automatic liquid line flushing make the equipment not only powerful but also compact, greatly improving the user's work efficiency.
Application scenarios | hospitals,clinic,clinical,laboratory |
| Fluorescence sensitivity | FITC≤150MESF，PE≤80MESF |
Forward detection sensitivity | ≤1um |
Lateral detection sensitivity | ≤0.5um |
Pollution carrying rate | ≤0.1% |
Maximum test rate | ≤50000 cells /s |
Sample test | Blood |
The CytoPOC flow cytometer adopts a single light source and four-color configuration to ensure the stability and consistency of the light source during the detection process. The design of a fixed non-dimming path simplifies the operation process and reduces possible sources of error. Dual-platform absolute counting technology provides more accurate cell counting results and provides reliable data support for clinical diagnosis.
Clinical application:
a. Lymphocyte subpopulation analysis and absolute count: Through the identification of T/B/NK cells and the detection of HLA-B27, doctors can quickly understand the patient's immune status and evaluate autoimmune diseases.
b. Classification of blood diseases/lymphomas: DNA ploidy analysis can assist in the diagnosis of various types of blood diseases and lymphomas and provide a basis for the selection of treatment options.
c. Functional lymphocyte subpopulation analysis: Functional analysis of Th1, Treg and other cells is crucial to understanding the patient's immune response, especially in the treatment of tumors and infectious diseases.
d. CD34 hematopoietic stem cell count: For patients undergoing bone marrow transplantation and recovery treatment, the accurate count of CD34 cells is an important indicator to evaluate the effect of treatment.
e. Auxiliary diagnosis of PNH: Platelet analysis and reticulocyte count can provide important information for the diagnosis of PNH (paroxysmal nocturnal hemoglobinuria).
f. Multiple myeloma surveillance: In the management of multiple myeloma, platelet analysis is critical to assess disease progression and response to treatment.
g. Detection of minimal residual disease in acute leukemia: By monitoring residual disease, the effect of treatment can be evaluated and follow-up treatment strategies can be guided.
h. Drug efficacy monitoring: Real-time monitoring of the effects of drugs on specific cell populations helps to formulate personalized treatment plans.
Fluorescence channel | filter | Recommend the dye |
FL1 | 530/30 nm | FITC |
FL2 | 585/40 nm | PE |
FL3 | 670LP | PerCP |
FL4 | 785/60 nm | PE-CY7 |
The performance parameters：
Fluorescence sensitivity FITC ≤150MESF
PE ≤80MESF
Forward detection sensitivity ≤1um
Lateral detection sensitivity ≤0.5um
Pollution carrying rate ≤0.1%
Maximum test rate ≤50000 cells /s
